| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 06/07/2001 | WO2001039771A1 Use of melatonin for treating androgenetic and diffuse alopecia |
| 06/07/2001 | WO2001030749B1 Novel compounds |
| 06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
| 06/07/2001 | WO2001012187A3 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/07/2001 | WO2000069424A3 Method of treating psychotic disorders |
| 06/07/2001 | US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant |
| 06/07/2001 | CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 06/07/2001 | CA2391646A1 Solid preparation |
| 06/07/2001 | CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/06/2001 | EP1104297A1 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 06/06/2001 | EP1104292A2 Treatment of vasodilatory headache |
| 06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1298399A Substituted alxoxycarbonyl compounds |
| 06/06/2001 | CN1298390A Arylphenyl-substituted cyclic keto-enols |
| 06/06/2001 | CN1298304A Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 06/05/2001 | US6242645 Biological activity enhancer, deoxofluorination agent of interest in medicinal and agrochemical products |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 06/05/2001 | US6242609 Ammonium trihalide for halogenation of color couplers and silver halide emulsions |
| 06/05/2001 | US6242495 Compounds and compositions for delivering active agents |
| 06/05/2001 | US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents |
| 06/05/2001 | US6242493 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/05/2001 | US6242481 Administering cytochalasin derivative as anticarcinogenic or antitumor agent |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242449 Treating prostatic hypertrophy, urination disorders associated with prostatic hypertrophy, male pattern alopecia, or acne |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | CA2059647C Thiocylating reagents and intermediates, thiopeptides, and methods for preparing and using same |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | WO2001037819A2 Use of indirubine derivatives for making medicines |
| 05/31/2001 | WO2000077032A3 Spermine:peptide-based surfactant compounds |
| 05/31/2001 | WO2000032196A3 Inhibitors of multidrug transporters |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | US20010002401 Establishing the status of the mammal as presently or prospectively being in early stages of degeneration of articular cartilage or subchondral bone in one or more joinsts, administering a xanthine chondroprotective compound |
| 05/31/2001 | DE19957710A1 Treating female type androgenetic or diffuse alopecia by topical administration of melatonin, causing e.g. reduction of telogen rate and increase of anagen rate, hair diameter and tensile strength |
| 05/31/2001 | CA2392225A1 Novel il-8 receptor antagonists |
| 05/31/2001 | CA2387591A1 Use of indirubine derivatives for making medicines |
| 05/30/2001 | EP1103549A1 Photoprotective cosmetic compositions containing aminoamidine derivatives and uses thereof |
| 05/30/2001 | EP1103536A1 Process for the preparation of chiral amines by asymmetric hydrogenation of enamines |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP1102535A2 Compounds and methods |
| 05/30/2001 | EP0719254B1 Method for the preparation of high purity substituted benz e]indoles and the alkaline salts thereof |
| 05/30/2001 | CN1297439A 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists |
| 05/30/2001 | CN1297438A Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes |
| 05/30/2001 | CN1297437A Substd. 2-oxo-alkanoic acid-[2-(indol-3-yl)-ethyl] amides |
| 05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 05/29/2001 | US6239161 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 05/29/2001 | US6239154 Arylacetamides, agonists at kappa opioid receptors. |
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/29/2001 | US6239143 5-HT7 receptor antagonists |
| 05/29/2001 | US6239129 Characterised by an indole ring on the aromatic moiety by a cyano group and on the indole nitrogen by an aminoalkyl chain. great affinity for 5-ht2c receptors, useful for depression, panic attacks, obsessive-compulsive disorders, phobias, |
| 05/29/2001 | CA2325783A1 Ultraviolet-protecting cosmetic compounds containing amino- amidine derivatives and uses |
| 05/25/2001 | WO2001036413A1 Aryloxy propanolamines for improving livestock production |
| 05/25/2001 | WO2001036375A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
| 05/25/2001 | WO2001035958A1 Carvedilol methanesulfonate |
| 05/25/2001 | WO2000077027A3 Serine protease inhibitors |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2001 | CA2392085A1 Carvedilol methanesulfonate |
| 05/25/2001 | CA2391654A1 Aryloxy propanolamines for improving livestock production |
| 05/24/2001 | US20010001799 Anticoagulant |
| 05/23/2001 | EP1101770A1 Derivatives of 12,13-(pyranosyl)-indolo(2,3-a)pyrrolo(3,4-c)carbazole and 12,13-(pyranosyl)-furo(3,4-c)indolo(2,3-a)carbazole, their process of preparation and pharmaceutical compositions containing them |
| 05/23/2001 | EP1101756A1 Aminopyrrolidine derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| 05/23/2001 | EP1100805A1 Medicine nitrate salts |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100789A1 Substituted benzoylcyclohexandiones |
| 05/23/2001 | EP1100780A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz f]indoles, a method for the production thereof, and their use as medicaments |
| 05/23/2001 | EP1100779A1 Substituted indolinones, the production thereof and their use as medicaments |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100495A1 Propenamides as ccr5 modulators |
| 05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP0680950B1 Propenone derivatives |
| 05/23/2001 | CN1296485A Substituted indolealkanoic acids |
| 05/22/2001 | US6235936 Transition metal catalyst for arylation |
| 05/22/2001 | US6235925 Process for synthesizing khi-substituted ring systems |
| 05/22/2001 | US6235866 Slurry preparation of bis (halophthalimides) and of polyether polymers |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235770 Anticholesterol agents |
| 05/22/2001 | US6235768 Osteoporosis; rheumatic disorders; antitumor agents |
| 05/22/2001 | US6235764 Isothiazole derivatives useful as anticancer agents |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235744 Synergistic mixture |
| 05/17/2001 | WO2001034606A1 Pharmaceutically active isoindoline derivatives |
| 05/17/2001 | WO2001034578A1 Compounds with anti-helicobacter pylori activity |
| 05/17/2001 | WO2001034573A1 Compounds |
| 05/17/2001 | WO2001034561A1 Processes for the preparation of sumatriptan and related compounds |
| 05/17/2001 | WO2001034146A1 Novel anti-infectives |
| 05/17/2001 | WO2001034127A1 Prevention of plaque rupture by acat inhibitors |
| 05/17/2001 | WO2001007408A3 Novel method for preparing benzoperhydroisoindole compounds |
| 05/17/2001 | CA2389514A1 Processes for the preparation of sumatriptan and related compounds |
| 05/17/2001 | CA2382676A1 Prevention of plaque rupture by acat inhibitors |
| 05/16/2001 | EP1099691A1 N-Sulfonyloxyimide compound and radiation-sensitive resin composition using the same |
| 05/16/2001 | EP1098864A1 Method for hydrogenating unsaturated heterocyclic compounds |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP1098627A1 Colorant for colouring keratin fibres |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 05/16/2001 | CN1295064A Novel tricyclic compound and medicine composition containing the same |